LinkGevity is an innovative drug discovery company based at the Babraham Research Campus in Cambridge, UK. Founded on groundbreaking research in longevity science, their mission is to extend healthspan and improve quality of life through advanced AI technology and their proprietary Blueprint Theory of aging. 

The company has been recognized for its work, including selection for the NASA/Microsoft Space-Health Program and the KQ Labs Programme at the Francis Crick Institute.